Navigation
Excelsio Media by Nelson Alarcón - alarcónnelson

Novavax vaccine over 90% effective in U.S. trial

Novavax vaccine over 90% effective in U.S. trial
Novavax reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus.

Share

Excelsio Media

EXCELSIO Media, is an independent source of news and information.

Post A Comment:

0 comments:

Leave a comment. Thanks!